Overview
Emir Hadzijusufovic practices practicing medicine in Vienna, Austria.
Mr. Hadzijusufovic is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Chronic Myelogenous Leukemia (CML), and Leukemia.
He is actively involved in clinical research, co-authoring 58 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Emir Hadzijusufovic
Is Emir Hadzijusufovic a top-rated expert for Mast Cell Activation Syndrome (MCAS)?
MediFind is an objective health platform that identifies experts based on real-world data. Emir Hadzijusufovic is classified as an Elite expert for Mast Cell Activation Syndrome (MCAS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Emir Hadzijusufovic participate in research or clinical trials?
Yes. Emir Hadzijusufovic has published 58 articles and abstracts on conditions like Mast Cell Activation Syndrome (MCAS). You can view a list of Emir Hadzijusufovic's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mast Cell Activation Syndrome (MCAS)Mr. Hadzijusufovic isElite. Learn about Mast Cell Activation Syndrome (MCAS).
- Systemic MastocytosisMr. Hadzijusufovic isElite. Learn about Systemic Mastocytosis.
- Advanced
- Chronic Myelogenous Leukemia (CML)Mr. Hadzijusufovic isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Essential ThrombocythemiaMr. Hadzijusufovic isAdvanced. Learn about Essential Thrombocythemia.
- LeukemiaMr. Hadzijusufovic isAdvanced. Learn about Leukemia.
- Myeloproliferative Neoplasms (MPN)Mr. Hadzijusufovic isAdvanced. Learn about Myeloproliferative Neoplasms (MPN).
- Polycythemia VeraMr. Hadzijusufovic isAdvanced. Learn about Polycythemia Vera.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Hadzijusufovic isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AtherosclerosisMr. Hadzijusufovic isExperienced. Learn about Atherosclerosis.
- Blood ClotsMr. Hadzijusufovic isExperienced. Learn about Blood Clots.
- Lymphofollicular HyperplasiaMr. Hadzijusufovic isExperienced. Learn about Lymphofollicular Hyperplasia.
- MyelofibrosisMr. Hadzijusufovic isExperienced. Learn about Myelofibrosis.